Monday, November 13, 2017

But of course



Azar has spent most of the past decade inside the drug industry, one of the key sectors he’ll regulate at HHS. Azar joined pharmaceutical giant Eli Lilly and Company in June 2007 as a senior vice president of corporate affairs and communications right after leaving the Bush administration [where he served as deputy secretary of HHS].

[...]

As part of his role at Lilly, Azar served on the board of directors for BIO, a drug lobby.

[...]

Though Trump condemned pharma campaign donations in a Rose Garden press conference on Monday, Azar was one of many drug industry executives who contributed to his campaign.

  Politico
...but hey, do what you want...you will anyway.

No comments: